A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients
Clinical trial NCT03145961 · UNKNOWN
Trial details
- NCT number
- NCT03145961
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2021-09-30
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.